日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Synthesis and Characterization of Gum Kondagogu Stabilized Zinc Oxide Nanoparticles and Its Application as an Antibacterial Agent Against Wastewaterborne Bacteria

合成与表征康达果胶稳定氧化锌纳米粒子及其作为废水抗菌剂的应用

期刊:Apmis
影响因子:2.6
doi:10.1111/apm.70046
Kora, Aruna Jyothi; Mullapudi, Venkata Balarama Krishna
发表日期：2025
文献求助 收藏

Tracking microplastic pathways: Real-time IoT monitoring for water quality and public health

追踪微塑料路径：利用物联网实时监测水质和公共卫生

期刊:MethodsX
影响因子:1.9
doi:10.1016/j.mex.2025.103674
Govindarajan, Priya; Shahapuram, Veena Krishna; Ganesh, Prajanya ShivajiRao; Basavalingappa, Vachana Manjunatha; Balarama, Keerthana Yenneholekoppal; Sarangi, Prakash Kumar; Cheong, Jun Young; Padil, Vinod Vellora Thekkae
发表日期：2025
文献求助 收藏

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

Tafamidis 对转甲状腺素蛋白淀粉样变性心肌病患者心脏功能的影响：ATTR-ACT 随机临床试验的事后分析

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2023.4147
Shah, Sanjiv J; Fine, Nowell; Garcia-Pavia, Pablo; Klein, Allan L; Fernandes, Fabio; Weissman, Neil J; Maurer, Mathew S; Boman, Kurt; Gundapaneni, Balarama; Sultan, Marla B; Elliott, Perry
心血管
心肌病
免疫/内分泌
发表日期：2024
文献求助 收藏

Effect of Tafamidis on Renal Function in Patients With Transthyretin Amyloid Cardiomyopathy in ATTR-ACT

在ATTR-ACT研究中，他法米地对转甲状腺素蛋白淀粉样变性心肌病患者肾功能的影响

期刊:Jacc: Cardiooncology
影响因子:12.8
doi:10.1016/j.jaccao.2024.02.007
Sperry, Brett W; Sultan, Marla B; Gundapaneni, Balarama; Tai, Sandi See; Witteles, Ronald M
心血管
心肌病
免疫/内分泌
发表日期：2024
文献求助 收藏

Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid Cardiomyopathy

心房颤动是转甲状腺素蛋白淀粉样变性心肌病患者全因死亡率的预后因素

期刊:Jacc: Cardiooncology
影响因子:12.8
doi:10.1016/j.jaccao.2024.03.007
Witteles, Ronald; Jefferies, John L; Kapa, Suraj; Cappelli, Francesco; Sultan, Marla B; Gundapaneni, Balarama; Davis, Margot K; Garcia-Pavia, Pablo
心血管
心肌病
免疫/内分泌
发表日期：2024
文献求助 收藏

The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): A plain language summary

长期服用他法米地对转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM）患者生活质量的影响：简明扼要的总结

期刊:Future Cardiology
影响因子:1
doi:10.1080/14796678.2024.2391250
Grogan, Martha; Davis, Margot K; Crespo Leiro, Maria G; Sultan, Marla B; Gundapaneni, Balarama; Angeli, Franca Stedile; Hanna, Mazen
心血管
心肌病
免疫/内分泌
发表日期：2024
文献求助 收藏

Radical versus Local Surgical Excision for Early Rectal Cancer: A Systematic Review and Meta-Analysis

早期直肠癌根治性切除术与局部手术切除术的比较：系统评价和荟萃分析

期刊:
影响因子:
doi:10.26502/aimr.0160
El-Nakeep, Sarah; Madala, Samragnyi; Chidharla, Anusha; Surapaneni, Balarama Krishna; Saha, Subhrajit; Martin, Benjamin; Kasi, Anup
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial

在Tafamidis治疗转甲状腺素蛋白心肌病临床试验中，Tafamidis疗效指标有所改善

期刊:JACC Advances
影响因子:
doi:10.1016/j.jacadv.2022.100148
Hanna, Mazen; Fine, Nowell M; Gundapaneni, Balarama; Sultan, Marla B; Witteles, Ronald M
心血管
心肌病
免疫/内分泌
发表日期：2022
文献求助 收藏

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study

转甲状腺素蛋白心肌病Tafamidis临床试验（ATTR-ACT）及其长期扩展研究中Tafamidis剂量的疗效和安全性

期刊:European Journal of Heart Failure
影响因子:10.8
doi:10.1002/ejhf.2027
Damy, Thibaud; Garcia-Pavia, Pablo; Hanna, Mazen; Judge, Daniel P; Merlini, Giampaolo; Gundapaneni, Balarama; Patterson, Terrell A; Riley, Steven; Schwartz, Jeffrey H; Sultan, Marla B; Witteles, Ronald
心血管
心肌病
免疫/内分泌
发表日期：2021
文献求助 收藏

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT

转甲状腺素蛋白淀粉样变性心肌病的自然史和进展：来自 ATTR-ACT 研究的启示

期刊:Esc Heart Failure
影响因子:3.7
doi:10.1002/ehf2.13541
Nativi-Nicolau, Jose; Judge, Daniel P; Hoffman, James E; Gundapaneni, Balarama; Keohane, Denis; Sultan, Marla B; Grogan, Martha
心血管
心肌病
免疫/内分泌
发表日期：2021
文献求助 收藏